{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:03:33Z","timestamp":1787241813122,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IOC"},{"DOI":"10.13039\/501100006507","name":"FIOCRUZ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bcp.2017.08.025","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T20:00:45Z","timestamp":1504814445000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy"],"prefix":"10.1016","volume":"145","author":[{"given":"M.R.","family":"Sim\u00f5es-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"De Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Demarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"D'Almeida-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.J.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cardoso-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.C.","family":"Soeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.08.025_b0005","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1073\/pnas.0307312101","article-title":"A 9,000-year record of Chagas\u2019 disease","volume":"101","author":"Aufderheide","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2017.08.025_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0074-02762009000900004","article-title":"Paleoparasitology of Chagas disease \u2013 a review","volume":"104","author":"Ara\u00fajo","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bcp.2017.08.025_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanosomiase humana: Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi, gen. n. sp., agente etiol\u00f3gico de nova entidade m\u00f3rbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of Chagas disease","volume":"1","author":"Prata","year":"2001","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.bcp.2017.08.025_b0025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2017.08.025_b0030","doi-asserted-by":"crossref","first-page":"e0003895","DOI":"10.1371\/journal.pntd.0003895","article-title":"Eliminating the neglected tropical diseases: translational science and new technologies","volume":"10","author":"Hotez","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.bcp.2017.08.025_b0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1590\/0074-0276130565","article-title":"Chagas disease: control, elimination and eradication. Is it possible?","volume":"108","author":"Coura","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"90","key":"10.1016\/j.bcp.2017.08.025_b0040","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on estimates","volume":"2015","author":"WHO (World Health Organization)","year":"2010","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2017.08.025_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","article-title":"Chagas disease in Spain, the United States and other non-endemic countries","volume":"115","author":"Gascon","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.bcp.2017.08.025_b0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and Chagas\u2019 disease in the United States","volume":"24","author":"Bern","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2017.08.025_b0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1590\/0074-0276140236","article-title":"Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries","volume":"109","author":"Coura","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bcp.2017.08.025_b0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.actatropica.2015.04.029","article-title":"Ecological diversity of Trypanosoma cruzi transmission in the Amazon basin. The main scenaries in the Brazilian Amazon","volume":"151","author":"Coura","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.bcp.2017.08.025_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.bcp.2017.08.025_b0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bcp.2017.08.025_b0075","unstructured":"Drugs for Neglected Diseases Initiative [homepage on the Internet]. Chagas disease Target Product Profile. Available from: http:\/\/www.dndi.org\/diseases-projects\/portfolio.html (accessed April 4, 2017)."},{"issue":"8","key":"10.1016\/j.bcp.2017.08.025_b0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: The STOP-CHAGAS Trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.bcp.2017.08.025_b0085","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for Chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2017.08.025_b0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc.11.95","article-title":"Drug repositioning in the treatment of malaria and TB","volume":"3","author":"Nzila","year":"2011","journal-title":"Future Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2017.08.025_b0095","doi-asserted-by":"crossref","first-page":"e1920","DOI":"10.1371\/journal.pntd.0001920","article-title":"In-hospital safety in field conditions of nifurtimox-eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness","volume":"6","author":"Schmid","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: M\u00e9decins Sans Fronti\u00e8res experience on the Democratic Republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2017.08.025_b0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0074-02762009000400002","article-title":"Present situation and new strategies for Chagas disease chemotherapy: a proposal","volume":"104","author":"Coura","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bcp.2017.08.025_b0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2016.07.019","article-title":"An up-date on Giardia and giardiasis","volume":"34","author":"Einarsson","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"issue":"9","key":"10.1016\/j.bcp.2017.08.025_b0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.15698\/mic2016.09.526","article-title":"Trichomoniasis \u2013 are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?","volume":"3","author":"Menezes","year":"2016","journal-title":"Microb. Cell"},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0120","first-page":"311","article-title":"The aerobic metabolism of metronidazole by Trypanosoma cruzi epimastigotes","volume":"75","author":"Agosin","year":"1983","journal-title":"Comp. Biochem. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2017.08.025_b0125","first-page":"951","article-title":"Ultrastructural modifications during the metabolism of metronidazole by Trypanosoma cruzi","volume":"15","author":"Paulin","year":"1983","journal-title":"J. Submicrosc. Cytol."},{"issue":"3","key":"10.1016\/j.bcp.2017.08.025_b0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S0037-86821970000300003","article-title":"Tratamento, pelo metronidazol, de pacientes com a forma cr\u00f4nica da doen\u00e7a de Chagas","volume":"IV","author":"Levi","year":"1970","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.bcp.2017.08.025_b0135","first-page":"5","article-title":"Forma aguda de la enfermedad de Chagas, import\u00e2ncia semiol\u00f3gica del Signo de Romana \u2013 Informe de los dos primeiros casos em Honduras","volume":"39","author":"Lainez","year":"1971","journal-title":"Ver. Med. Hondur."},{"key":"10.1016\/j.bcp.2017.08.025_b0140","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1128\/AAC.01788-15","article-title":"Phenotypic screening in vitro of novel aromatic amidines against Trypanosoma cruzi","volume":"60","author":"Sim\u00f5es-Silva","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2017.08.025_b0145","doi-asserted-by":"crossref","first-page":"pii:e02098","DOI":"10.1128\/AAC.02098-16","article-title":"Antitrypanosomal activity of sterol 14\u03b1-demethylase (CYP51) inhibitors VNI and VFV in the Swiss mouse models of Chagas disease induced by the Trypanosoma cruzi Y strain","volume":"61","author":"Guedes-da-Silva","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0150","first-page":"198","article-title":"Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro","volume":"41","author":"Meirelles","year":"1986","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.bcp.2017.08.025_b0155","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01617-09","article-title":"Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment","volume":"54","author":"Batista","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2017.08.025_b0160","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2017.08.025_b0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for Chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"11","key":"10.1016\/j.bcp.2017.08.025_b0170","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bcp.2017.08.025_b0175","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"Diniz","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2017.08.025_b0180","doi-asserted-by":"crossref","first-page":"e30356","DOI":"10.1371\/journal.pone.0030356","article-title":"In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated saltform \u2013 DB1965 \u2013 against Trypanosoma cruzi infection","volume":"7","author":"Da Silva","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2017.08.025_b0185","first-page":"386","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev Inst. Med. Trop. de S\u00e3o Paulo"},{"issue":"4","key":"10.1016\/j.bcp.2017.08.025_b0190","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01667-15","article-title":"In vitro and in vivo trypanosomicydal action of novel arylimidamides against Trypanosoma cruzi","volume":"60","author":"Guedes-da-Silva","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1645\/15-884","article-title":"Use of noninvasive parameters to evaluate Swiss Webster mice during Trypanosoma cruzi experimental acute infection","volume":"102","author":"Campos","year":"2016","journal-title":"J. Parasitol."},{"issue":"3","key":"10.1016\/j.bcp.2017.08.025_b0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/3.3.205","article-title":"Metronidazole: review of uses and toxicity","volume":"3","author":"Roe","year":"1977","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.bcp.2017.08.025_b0205","doi-asserted-by":"crossref","first-page":"e0135556","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2017.08.025_b0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0035-9203(81)90015-8","article-title":"Trypanosoma (Schizotrypanum) dionisii as a model for chemotherapeutic studies related to Chagas's disease","volume":"75","author":"Baker","year":"1981","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.bcp.2017.08.025_b0215","first-page":"94","article-title":"The clinical experience in Panama with metronidazole in treating Chagas\u2019 disease in the acute and chronic phases","volume":"18","author":"Bland\u00f3n","year":"1993","journal-title":"Rev. Med. Panama"},{"issue":"7","key":"10.1016\/j.bcp.2017.08.025_b0220","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1039\/C4OB02561J","article-title":"Synthesis of imidazoles via cascade reaction of nitroallylic acetates with amidines and studies on their trypanocidal activity","volume":"13","author":"Kumar","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2017.08.025_b0225","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0278-6915(94)00136-C","article-title":"Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures","volume":"33","author":"Lipnick","year":"1995","journal-title":"Food Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.bcp.2017.08.025_b0230","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1128\/AAC.01294-15","article-title":"Different therapeutic outcomes of benznidazole and VNI treatments in different genders in mouse experimental models of Trypanosoma cruzi infection","volume":"59","author":"Guedes-da-Silva","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.bcp.2017.08.025_b0235","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/AAC.05785-11","article-title":"Preclinical monitoring of drug association in experimental chemotherapy of Chagas\u2019 disease by a new HPLC-UV method","volume":"56","author":"Moreira da Silva","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217305634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217305634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T03:18:32Z","timestamp":1570072712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217305634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":47,"alternative-id":["S0006295217305634"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.08.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}